1.Surgical Deroofing of Auricular Pseudocysts: Two Case Reports
Kunyong SUNG ; Heejeong PARK ; Seung Ho LEE ; Sang-Yeul LEE
Korean Journal of Head and Neck Oncology 2025;41(1):5-8
An auricular pseudocyst is an uncommon, benign cystic lesion that frequently occurs in the auricles of middle-aged male patients, characterized histologically by an intracartilaginous, non-epithelial-lined cystic space. This report presents two cases of auricular pseudocysts successfully treated using deroofing procedures, with excellent long-term outcomes observed at 6-month and 5-year follow-up, respectively. Although various treatment modalities may be employed for these lesions, surgical deroofing is considered a conventional and reliable option that provides low recurrence rates and superior aesthetic outcomes.
2.Surgical Deroofing of Auricular Pseudocysts: Two Case Reports
Kunyong SUNG ; Heejeong PARK ; Seung Ho LEE ; Sang-Yeul LEE
Korean Journal of Head and Neck Oncology 2025;41(1):5-8
An auricular pseudocyst is an uncommon, benign cystic lesion that frequently occurs in the auricles of middle-aged male patients, characterized histologically by an intracartilaginous, non-epithelial-lined cystic space. This report presents two cases of auricular pseudocysts successfully treated using deroofing procedures, with excellent long-term outcomes observed at 6-month and 5-year follow-up, respectively. Although various treatment modalities may be employed for these lesions, surgical deroofing is considered a conventional and reliable option that provides low recurrence rates and superior aesthetic outcomes.
3.Surgical Deroofing of Auricular Pseudocysts: Two Case Reports
Kunyong SUNG ; Heejeong PARK ; Seung Ho LEE ; Sang-Yeul LEE
Korean Journal of Head and Neck Oncology 2025;41(1):5-8
An auricular pseudocyst is an uncommon, benign cystic lesion that frequently occurs in the auricles of middle-aged male patients, characterized histologically by an intracartilaginous, non-epithelial-lined cystic space. This report presents two cases of auricular pseudocysts successfully treated using deroofing procedures, with excellent long-term outcomes observed at 6-month and 5-year follow-up, respectively. Although various treatment modalities may be employed for these lesions, surgical deroofing is considered a conventional and reliable option that provides low recurrence rates and superior aesthetic outcomes.
4.Surgical Deroofing of Auricular Pseudocysts: Two Case Reports
Kunyong SUNG ; Heejeong PARK ; Seung Ho LEE ; Sang-Yeul LEE
Korean Journal of Head and Neck Oncology 2025;41(1):5-8
An auricular pseudocyst is an uncommon, benign cystic lesion that frequently occurs in the auricles of middle-aged male patients, characterized histologically by an intracartilaginous, non-epithelial-lined cystic space. This report presents two cases of auricular pseudocysts successfully treated using deroofing procedures, with excellent long-term outcomes observed at 6-month and 5-year follow-up, respectively. Although various treatment modalities may be employed for these lesions, surgical deroofing is considered a conventional and reliable option that provides low recurrence rates and superior aesthetic outcomes.
5.The first Korean carbon-ion radiation therapy facility: current status of the Heavy-ion Therapy Center at the Yonsei Cancer Center
Min Cheol HAN ; Seo Hee CHOI ; Chae-Seon HONG ; Yong Bae KIM ; Woong Sub KOOM ; Jin Sung KIM ; Jaeho CHO ; Chan Woo WEE ; Changhwan KIM ; Jong Won PARK ; Soorim HAN ; Heejeong LEE ; Hong In YOON ; Ik Jae LEE ; Ki Chang KEUM
Radiation Oncology Journal 2024;42(4):295-307
Purpose:
This report offers a detailed examination of the inception and current state of the Heavy-ion Therapy Center (HITC) at the Yonsei Cancer Center (YCC), setting it apart as the world’s first center equipped with a fixed beam and two superconducting gantries for carbon-ion radiation therapy (CIRT).
Materials and Methods:
Preparations for CIRT at YCC began in 2013; accordingly, this center has completed a decade of meticulous planning and culminating since the operational commencement of the HITC in April 2023.
Results:
This report elaborates on the clinical preparation for adopting CIRT in Korea. It includes an extensive description of HITC’s facility layout at YCC, which comprises the accelerator and treatment rooms. Furthermore, this report delineates the clinical workflow, criteria for CIRT application, and the rigorous quality assurance processes implemented at YCC. It highlights YCC’s sophisticated radiation therapy infrastructure, collaborative initiatives, and the efficacious treatment of >200 prostate cancer cases utilizing CIRT.
Conclusion
This manuscript concludes by discussing the prospective influence of CIRT on the medical domain within Korea, spotlighting YCC’s pioneering contribution and forecasting the widespread integration of this groundbreaking technology.
6.The first Korean carbon-ion radiation therapy facility: current status of the Heavy-ion Therapy Center at the Yonsei Cancer Center
Min Cheol HAN ; Seo Hee CHOI ; Chae-Seon HONG ; Yong Bae KIM ; Woong Sub KOOM ; Jin Sung KIM ; Jaeho CHO ; Chan Woo WEE ; Changhwan KIM ; Jong Won PARK ; Soorim HAN ; Heejeong LEE ; Hong In YOON ; Ik Jae LEE ; Ki Chang KEUM
Radiation Oncology Journal 2024;42(4):295-307
Purpose:
This report offers a detailed examination of the inception and current state of the Heavy-ion Therapy Center (HITC) at the Yonsei Cancer Center (YCC), setting it apart as the world’s first center equipped with a fixed beam and two superconducting gantries for carbon-ion radiation therapy (CIRT).
Materials and Methods:
Preparations for CIRT at YCC began in 2013; accordingly, this center has completed a decade of meticulous planning and culminating since the operational commencement of the HITC in April 2023.
Results:
This report elaborates on the clinical preparation for adopting CIRT in Korea. It includes an extensive description of HITC’s facility layout at YCC, which comprises the accelerator and treatment rooms. Furthermore, this report delineates the clinical workflow, criteria for CIRT application, and the rigorous quality assurance processes implemented at YCC. It highlights YCC’s sophisticated radiation therapy infrastructure, collaborative initiatives, and the efficacious treatment of >200 prostate cancer cases utilizing CIRT.
Conclusion
This manuscript concludes by discussing the prospective influence of CIRT on the medical domain within Korea, spotlighting YCC’s pioneering contribution and forecasting the widespread integration of this groundbreaking technology.
7.The first Korean carbon-ion radiation therapy facility: current status of the Heavy-ion Therapy Center at the Yonsei Cancer Center
Min Cheol HAN ; Seo Hee CHOI ; Chae-Seon HONG ; Yong Bae KIM ; Woong Sub KOOM ; Jin Sung KIM ; Jaeho CHO ; Chan Woo WEE ; Changhwan KIM ; Jong Won PARK ; Soorim HAN ; Heejeong LEE ; Hong In YOON ; Ik Jae LEE ; Ki Chang KEUM
Radiation Oncology Journal 2024;42(4):295-307
Purpose:
This report offers a detailed examination of the inception and current state of the Heavy-ion Therapy Center (HITC) at the Yonsei Cancer Center (YCC), setting it apart as the world’s first center equipped with a fixed beam and two superconducting gantries for carbon-ion radiation therapy (CIRT).
Materials and Methods:
Preparations for CIRT at YCC began in 2013; accordingly, this center has completed a decade of meticulous planning and culminating since the operational commencement of the HITC in April 2023.
Results:
This report elaborates on the clinical preparation for adopting CIRT in Korea. It includes an extensive description of HITC’s facility layout at YCC, which comprises the accelerator and treatment rooms. Furthermore, this report delineates the clinical workflow, criteria for CIRT application, and the rigorous quality assurance processes implemented at YCC. It highlights YCC’s sophisticated radiation therapy infrastructure, collaborative initiatives, and the efficacious treatment of >200 prostate cancer cases utilizing CIRT.
Conclusion
This manuscript concludes by discussing the prospective influence of CIRT on the medical domain within Korea, spotlighting YCC’s pioneering contribution and forecasting the widespread integration of this groundbreaking technology.
8.Unilateral Erythema Nodosum Mistaken for Cellulitis at Burns from Moxibustion
Chi Young BANG ; Heejeong PARK ; Chanho JEONG ; Seung Ho LEE ; Suk Joon OH ; Young-Joon RYU ; Kunyong SUNG
Journal of Korean Burn Society 2024;27(2):14-17
A 71-year-old female patient developed cellulitis-like lesions at the burns from moxibustion of the right calf. The lesion was unilateral, a single confluent lesion with swelling and tenderness. Oral antibiotic treatment was performed with a poor clinical response. The patient was hospitalized and received intravenous broad-spectrum antibiotics, but the lesion progressed without improvement. Considering the possibility of erythema nodosum, the prescription was changed to methylprednisolone, and the redness, warmth and swelling improved the day after. A skin biopsy revealed features suggestive of panniculitis
9.Unilateral Erythema Nodosum Mistaken for Cellulitis at Burns from Moxibustion
Chi Young BANG ; Heejeong PARK ; Chanho JEONG ; Seung Ho LEE ; Suk Joon OH ; Young-Joon RYU ; Kunyong SUNG
Journal of Korean Burn Society 2024;27(2):14-17
A 71-year-old female patient developed cellulitis-like lesions at the burns from moxibustion of the right calf. The lesion was unilateral, a single confluent lesion with swelling and tenderness. Oral antibiotic treatment was performed with a poor clinical response. The patient was hospitalized and received intravenous broad-spectrum antibiotics, but the lesion progressed without improvement. Considering the possibility of erythema nodosum, the prescription was changed to methylprednisolone, and the redness, warmth and swelling improved the day after. A skin biopsy revealed features suggestive of panniculitis
10.Unilateral Erythema Nodosum Mistaken for Cellulitis at Burns from Moxibustion
Chi Young BANG ; Heejeong PARK ; Chanho JEONG ; Seung Ho LEE ; Suk Joon OH ; Young-Joon RYU ; Kunyong SUNG
Journal of Korean Burn Society 2024;27(2):14-17
A 71-year-old female patient developed cellulitis-like lesions at the burns from moxibustion of the right calf. The lesion was unilateral, a single confluent lesion with swelling and tenderness. Oral antibiotic treatment was performed with a poor clinical response. The patient was hospitalized and received intravenous broad-spectrum antibiotics, but the lesion progressed without improvement. Considering the possibility of erythema nodosum, the prescription was changed to methylprednisolone, and the redness, warmth and swelling improved the day after. A skin biopsy revealed features suggestive of panniculitis

Result Analysis
Print
Save
E-mail